Notably, HMGB1 levels were found to increase after IL-6 levels in sepsis [11], and anti-HMGB1 antibody have been shown to reduce mortality, suggesting HMGB1 as a potential therapeutic target [14–16]. Here, IL6 is linked to Sepsis.